|
|
|
Schmidt & Clark, LLP Announces Trasylol Website
Legal Focuses |
2008/03/04 12:39
|
Schmidt & Clark, LLP, a nationally recognized drug litigation law firm has announced today that it has recently added additional content to its Trasylol recall website.
Trasylol has been marketed by Bayer for 14 years. Bayer marketed it aggressively until it was used in approximately 1/3 of all cardiac bypass surgeries. In the last two years, Trasylol has been linked to kidney or renal failure, heart attacks, strokes and approximately 22,000 deaths.
At the heart of current and pending litigation surrounding Trasylol side effects, is the fact that Bayer was aware of the potential problems over two years ago. A study connecting Trasylol and serious side effects was presented in January 2006, but the drug was not recalled until November 2007. Bayer failed to present their research to the FDA in their September 2006 meeting. The chairman of that FDA advisory panel, Dr. William Hiatt, said that he would have voted for a Trasylol recall back in 2006 if Bayer had not withheld the data from their study.
Michael E. Schmidt, Managing Partner of Schmidt & Clark, LLP has noticed an alarming number of inquiries to the firm related to Trasylol. Mr. Schmidt stated, “Our firm has substantial expertise in the areas drug litigation. As a result, we have received a number of inquiries from heart bypass surgery patients claiming serious or life-threatening side effects including death, kidney or renal failure, heart attacks, and strokes.”
Schmidt & Clark, LLP represents a number of Trasylol recall victims and continues to be contacted by victims of Trasylol on a frequent basis.
If you or a loved one has been the victim of a Trasylol induced side effect, the firm suggests that you visit their Trasylol website. The site includes detailed lawsuit information, news and more.
About Schmidt & Clark, LLP
Schmidt & Clark, LLP focuses on helping individuals and families. The firm has built a reputation for success, and represents their clients in group and individual lawsuits nationwide.
Although Schmidt & Clark, LLP is national in scope, they level the playing field for their clients by providing them with access to a level of professional legal representation previously available only to large corporations, while still providing personal attention to each client.
For more information on Schmidt & Clark, LLP or Trasylol lawsuits, please visit: http://www.schmidtandclark.com/Trasylol/ or call toll free 24 hrs/day (866) 588-0600. |
|
|
|
|
|
|
 |
Investment Fraud Litigation |
|
|
|
|
Securities fraud, also known as stock fraud and investment fraud, is a practice that induces investors to make purchase or sale decisions on the basis of false information, frequently resulting in losses, in violation of the securities laws. Securities Arbitration. Generally speaking, securities fraud consists of deceptive practices in the stock and commodity markets, and occurs when investors are enticed to part with their money based on untrue statements.
|
|
|
| |
| |
| |
|
The content contained on the web site has been prepared by Securities Law News as a service to the internet community and is not intended to constitute legal advice or a substitute for consultation with a licensed legal professional in a particular case. | Affordable Law Firm Website Design by Law Promo |
|
Legal News RSS Feed
